DK3013351T3 - Peptider og peptidmimetika i kombinationanvendelser og behandlinger til cancerpatient-subpopulationer - Google Patents

Peptider og peptidmimetika i kombinationanvendelser og behandlinger til cancerpatient-subpopulationer Download PDF

Info

Publication number
DK3013351T3
DK3013351T3 DK14818523.4T DK14818523T DK3013351T3 DK 3013351 T3 DK3013351 T3 DK 3013351T3 DK 14818523 T DK14818523 T DK 14818523T DK 3013351 T3 DK3013351 T3 DK 3013351T3
Authority
DK
Denmark
Prior art keywords
peptid
mimetics
peptides
treatments
cancer patient
Prior art date
Application number
DK14818523.4T
Other languages
English (en)
Inventor
Takumi Kawabe
Naoki Mine
Naoya Saito
Keiichi Sakakibara
Takuji Sato
Original Assignee
Canbas Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52141164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3013351(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Canbas Co Ltd filed Critical Canbas Co Ltd
Application granted granted Critical
Publication of DK3013351T3 publication Critical patent/DK3013351T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dermatology (AREA)
DK14818523.4T 2013-06-24 2014-06-24 Peptider og peptidmimetika i kombinationanvendelser og behandlinger til cancerpatient-subpopulationer DK3013351T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361838777P 2013-06-24 2013-06-24
PCT/IB2014/001579 WO2014207556A1 (en) 2013-06-24 2014-06-24 Peptides and peptidomimetics in combination uses and treatments for cancer patient subpopulations

Publications (1)

Publication Number Publication Date
DK3013351T3 true DK3013351T3 (da) 2020-01-27

Family

ID=52141164

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14818523.4T DK3013351T3 (da) 2013-06-24 2014-06-24 Peptider og peptidmimetika i kombinationanvendelser og behandlinger til cancerpatient-subpopulationer

Country Status (27)

Country Link
US (1) US9221872B2 (da)
EP (1) EP3013351B1 (da)
JP (1) JP6401255B2 (da)
KR (1) KR102247493B1 (da)
CN (1) CN105324121A (da)
AU (1) AU2014300713B2 (da)
BR (1) BR112015032542A2 (da)
CA (1) CA2916136C (da)
CL (1) CL2015003704A1 (da)
CY (1) CY1122523T1 (da)
DK (1) DK3013351T3 (da)
ES (1) ES2765300T3 (da)
HR (1) HRP20192264T1 (da)
HU (1) HUE046873T2 (da)
IL (1) IL243266B (da)
LT (1) LT3013351T (da)
MX (1) MX366341B (da)
MY (1) MY182232A (da)
PH (1) PH12015502855B1 (da)
PL (1) PL3013351T3 (da)
PT (1) PT3013351T (da)
RS (1) RS60180B1 (da)
RU (1) RU2732440C2 (da)
SG (1) SG11201510490VA (da)
SI (1) SI3013351T1 (da)
WO (1) WO2014207556A1 (da)
ZA (1) ZA201600089B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9273093B2 (en) 2012-10-11 2016-03-01 Protagonist Therapeutics, Inc. α4β7 peptide dimer antagonists
KR102236829B1 (ko) 2013-03-15 2021-04-07 프로타고니스트 테라퓨틱스, 인코포레이티드 헵시딘 유사체 및 이의 용도
AU2015258863B2 (en) 2014-05-16 2019-10-24 Protagonist Therapeutics, Inc. Alpha4beta7 integrin thioether peptide antagonists
AU2015289642B2 (en) 2014-07-17 2021-02-25 Protagonist Therapeutics, Inc. Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
EP3201217A4 (en) 2014-10-01 2018-07-18 Protagonist Therapeutics Inc. Novel cyclic monomer and dimer peptides having integrin antagonist activity
WO2016054411A1 (en) 2014-10-01 2016-04-07 Protagonist Therapeutics, Inc. NOVEL α4β7 PEPTIDE MONOMER AND DIMER ANTAGONISTS
US10787490B2 (en) 2015-07-15 2020-09-29 Protaganist Therapeutics, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
TWI805542B (zh) * 2015-10-23 2023-06-21 日商坎巴斯有限公司 用於癌症治療之肽及擬肽與ｔ細胞活化劑及／或查核點抑制劑之組合
US10149887B2 (en) 2015-10-23 2018-12-11 Canbas Co., Ltd. Peptides and peptidomimetics in combination with t cell activating and/or checkpoint inhibiting agents for cancer treatment
WO2017117411A1 (en) 2015-12-30 2017-07-06 Protagonist Therapeutics, Inc. Analogues of hepcidin mimetics with improved in vivo half lives
EP3432906A4 (en) 2016-03-23 2020-04-01 Protagonist Therapeutics, Inc. METHOD FOR SYNTHETIZING ALPHA4BETA7 PEPTIDE ANTAGONISTS
HRP20220479T1 (hr) 2016-06-01 2022-05-27 Athira Pharma, Inc. Spojevi
US10278957B2 (en) 2017-09-11 2019-05-07 Protagonist Therapeutics, Inc. Opioid agonist peptides and uses thereof
EP3749345A4 (en) 2018-02-08 2022-04-06 Protagonist Therapeutics, Inc. CONJUGATED HEPCIDIN MIMETICS
TW202019948A (zh) 2018-07-12 2020-06-01 美商領導醫療有限公司 介白素-23受體之肽抑制劑及其治療發炎疾病之用途
MX2022000397A (es) 2019-07-10 2022-04-25 Protagonist Therapeutics Inc Inhibidores peptídicos del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias.
CN118063554A (zh) 2020-01-15 2024-05-24 詹森生物科技公司 介白素-23受体的肽抑制剂及其治疗炎性疾病的用途
KR20220141808A (ko) 2020-01-15 2022-10-20 얀센 바이오테크 인코포레이티드 인터루킨-23 수용체의 펩티드 억제제 및 염증성 질환을 치료하기 위한 이의 용도
KR20230110570A (ko) 2020-11-20 2023-07-24 얀센 파마슈티카 엔.브이. 인터류킨-23 수용체의 펩티드 억제제의 조성물
TW202330013A (zh) 2021-07-14 2023-08-01 美商健生生物科技公司 介白素－２３受體之脂化肽抑制劑
CN115804834B (zh) * 2021-08-10 2025-10-21 昆明医科大学 一种具有提高免疫力和抗肿瘤以及延长寿命的多肽及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100863090B1 (ko) * 2002-01-17 2008-10-13 다케다 파머수티컬 컴패니 리미티드 항증식 활성을 지니고／지니거나 핵산 손상제 또는 처리제를 증강시키는 펩티드 및 펩티드모방체
EP1556398B1 (en) * 2002-10-31 2009-09-09 Metabasis Therapeutics, Inc. Novel cytarabine monophosphate prodrugs
US7125842B2 (en) * 2003-04-07 2006-10-24 Canbas Co. Ltd. Anti-fungal compounds and methods of use
CN1812805A (zh) * 2003-06-25 2006-08-02 坎巴斯有限公司 具有免疫调节活性、抗炎活性和抗病毒活性的肽和肽模仿物
PE20091924A1 (es) 2008-05-14 2010-01-04 Takeda Pharmaceutical Compuesto peptidico y su uso

Also Published As

Publication number Publication date
CL2015003704A1 (es) 2016-07-29
US9221872B2 (en) 2015-12-29
AU2014300713B2 (en) 2019-02-14
JP2016522245A (ja) 2016-07-28
EP3013351A1 (en) 2016-05-04
JP6401255B2 (ja) 2018-10-10
RU2016101718A (ru) 2017-07-28
CN105324121A (zh) 2016-02-10
IL243266B (en) 2019-11-28
AU2014300713A1 (en) 2016-01-21
MY182232A (en) 2021-01-18
RS60180B1 (sr) 2020-06-30
PT3013351T (pt) 2020-01-17
MX2015017609A (es) 2016-04-15
US20150056301A1 (en) 2015-02-26
HK1219905A1 (en) 2017-04-21
CY1122523T1 (el) 2021-01-27
KR102247493B1 (ko) 2021-04-30
NZ715285A (en) 2021-09-24
HUE046873T2 (hu) 2020-03-30
EP3013351A4 (en) 2017-03-01
EP3013351B1 (en) 2019-10-30
CA2916136A1 (en) 2014-12-31
PH12015502855B1 (en) 2022-02-11
SG11201510490VA (en) 2016-01-28
CA2916136C (en) 2022-10-18
KR20160021792A (ko) 2016-02-26
ES2765300T3 (es) 2020-06-08
BR112015032542A2 (pt) 2017-07-25
LT3013351T (lt) 2020-01-10
HRP20192264T1 (hr) 2020-03-06
IL243266A0 (en) 2016-03-31
MX366341B (es) 2019-07-05
PL3013351T3 (pl) 2020-05-18
WO2014207556A1 (en) 2014-12-31
SI3013351T1 (sl) 2020-03-31
RU2016101718A3 (da) 2018-03-01
RU2732440C2 (ru) 2020-09-16
ZA201600089B (en) 2020-02-26
PH12015502855A1 (en) 2016-04-04

Similar Documents

Publication Publication Date Title
ZA201600089B (en) Peptides and peptidomimetics in combination uses and treatments for cancer patient subpopulations
DK3686280T3 (da) Carbohydratdegraderende polypeptid og anvendelser deraf
DK3058936T3 (da) Peptidsammensætning og anvendelser deraf
SI2986304T1 (sl) Farmacevtski sestavek, postopki za zdravljenje in njegove uporabe
BR302013004536S1 (pt) Configuração aplicada em curativo médico
DK3294770T4 (da) Terapeutiske og diagnostiske fremgangsmåder til cancer
IL244744B (en) Matrix metalloproteinase cleavable polypeptides and uses thereof
BR302013004565S1 (pt) Configuração aplicada em curativo médico
DK2920197T3 (da) Prolinlåste sammenhæftede peptider og anvendelser deraf
BR112015032392A2 (pt) sistemas e métodos de entrega de terapia usando um dispositivo médico ambulatorial
DK3060237T3 (da) Modificeret omprogrammeringsprotein til anvendelse i behandling af cancer
DK2920313T3 (da) Rekombinante adenovira og anvendelse deraf
IL245540A0 (en) Systems, devices and methods for the creation of a therapeutic restriction in the gastrointestinal tract
DK3083616T3 (da) Bicykliske heterocykliske forbindelser og disses anvendelser i terapi
IL269741A (en) Peptides and combination thereof for use in the immunotherapy against cancers
PL3178849T3 (pl) Kombinacja przeciwciał anty-lag-3 i przeciwciał anty-pd-1 w leczeniu raka
BR302013006822S1 (pt) Configuração aplicada em curativo médico.
PL3542798T3 (pl) Aceklidyna do zastosowania w leczeniu starczowzroczności
BR302013004419S1 (pt) Configuração aplicada em instrumento médico
PL2958945T3 (pl) Terapia skojarzona wykorzystująca przeciwciała przeciwko klaudynie 18.2 do leczenia nowotworu
HRP20182125T1 (hr) Adenovirus koji izražava fas-himeru i korištenje istog u metodama liječenja raka
DK3065759T3 (da) Immunosuppressive midler og deres anvendelse i terapi
DK2883954T3 (da) Peptidbibliotek og anvendelse deraf
DK2967330T3 (da) Medicinsk indretning og eksterne indretningskoordineringssystemer og fremgangsmåder
HUE040418T2 (hu) Antimikrobiális peptid és felhasználásai